Abilities International Accessibility Conference is proud to welcome ONWARD Medical as a new Bronze Tier Sponsor for 2026. As a global leader in neurotechnology, ONWARD Medical is pioneering therapies designed to restore movement, function and independence for people living with spinal cord injury and other movement disabilities.
Building on decades of scientific discovery and clinical research conducted at leading hospitals and neuroscience laboratories, ONWARD developed ARC Therapy, an innovative platform designed to reactivate the nervous system. The company has received 10 FDA Breakthrough Device designations, reflecting the transformative potential of its work. Its ARC-EX System is now cleared for commercial sale in the United States and Europe, providing non-invasive spinal cord stimulation to support recovery and function.
ONWARD is also advancing ARC-IM, an investigational implantable system designed to address unmet needs including blood pressure instability after spinal cord injury. The technology has the potential to be paired with brain-computer interface and artificial intelligence systems to enable thought-driven movement.
Headquartered in the Netherlands, with a Science and Engineering Center in Switzerland and a US office in Boston, ONWARD is listed on Euronext Paris, Brussels and Amsterdam under the ticker ONWD, with US ADRs trading on OTCQX under ONWRY.
We are delighted to partner with ONWARD Medical as they continue to push the boundaries of neurotechnology and recovery science. Attendees in Los Angeles will have the opportunity to connect with their team and learn more about the future of restorative therapies.